GLS 409(GLSynthesis)

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGLS 409(GLSynthesis)
Drug Alias NameGLS-409
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionPurinergic receptor P2Y12 antagonists
TargetsPurinergic receptor P2Y12
Therapy Area/IndicationsCoronary Thrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlsynthesis Inc
China Registration ClassN/A

Develop Information

Active CompaniesGlsynthesis Inc
Inactive CompaniesN/A
Active IndicationsCoronary Thrombosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A